<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Perinatal <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> brain injury is a major cause of mortality and morbidity in neonates and lacks an effective treatment thus far </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="15727">Carnosine</z:chebi> has been demonstrated to play a neuroprotective role in the adult brain injuries </plain></SENT>
<SENT sid="2" pm="."><plain>However, there is no information available concerning its neuroprotective role in the immature brains after <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> insults </plain></SENT>
<SENT sid="3" pm="."><plain>Therefore, we investigated whether <z:chebi fb="0" ids="15727">carnosine</z:chebi> could also confer neuroprotective effects in a neonatal rat <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> model </plain></SENT>
<SENT sid="4" pm="."><plain><z:mp ids='MP_0005039'>Hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was induced in rats on postnatal day 7 (P7) </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="15727">Carnosine</z:chebi> (250 mg/kg) was administered intraperitoneally, 30 min prior to <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> induction </plain></SENT>
<SENT sid="6" pm="."><plain>Morphological brain injury and biochemical markers of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and <z:mp ids='MP_0003674'>oxidative stress</z:mp> were evaluated 24 h after <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> induction </plain></SENT>
<SENT sid="7" pm="."><plain>Cognitive performance was evaluated by the <z:mp ids='MP_0001465'>Morris Water Maze</z:mp> test on P28-P33 </plain></SENT>
<SENT sid="8" pm="."><plain>We found that pretreatment with <z:chebi fb="0" ids="15727">carnosine</z:chebi> significantly reduced the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and the number of terminal-deoxynucleotidyl transferase-mediated <z:chebi fb="0" ids="17625">dUTP</z:chebi> nick end labeling (TUNEL)-positive cells in the <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> brain </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="0" ids="15727">Carnosine</z:chebi> also inhibited <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-inducing factor(AIF) and caspase-3, which was accompanied by an increase in <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase(SOD)activity and a decrease in the malondialdehyde(<z:chebi fb="14" ids="32506">MDA</z:chebi>)level in <z:chebi fb="0" ids="15727">carnosine</z:chebi>-treated rats </plain></SENT>
<SENT sid="10" pm="."><plain>Furthermore, <z:chebi fb="0" ids="15727">carnosine</z:chebi> also improved the spatial learning and memory abilities of rats declined due to <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>These results demonstrate that <z:chebi fb="0" ids="15727">carnosine</z:chebi> can protect rats against <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced brain damage by antioxidation </plain></SENT>
</text></document>